Protara Therapeutics, Inc. (TARA)
3.35
-0.19
(-5.37%)
USD |
NASDAQ |
Sep 24, 16:00
3.345
0.00 (0.00%)
Pre-Market: 19:59
Protara Therapeutics Gross Profit (Annual) : -0.362M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.362M |
| December 31, 2024 | -0.332M |
| December 31, 2023 | -0.341M |
| December 31, 2022 | -0.247M |
| December 31, 2021 | -1.167M |
| December 31, 2020 | -0.196M |
| December 31, 2019 | -0.016M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.115M |
| December 31, 2017 | -0.148M |
| December 31, 2016 | -0.123M |
| December 31, 2015 | -0.057M |
| December 31, 2014 | 0.00 |
| December 31, 2013 | -0.027M |
| December 31, 2012 | -0.057M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | -0.199M |
| Summit Therapeutics, Inc. | -0.146M |
| Kezar Life Sciences, Inc. | -0.897M |
| Clene, Inc. | -1.338M |